Stay in the know
Receive timely insights and briefings from HSF Kramer, tailored to keep you informed and ahead
Subscribe now
- Bankruptcy and restructuring
- Bankruptcy litigation and investigations
- Bondholder, lender and other creditor representations
- Claims trading and investment advice
- Company turnaround and board advisory
- Creditor committee representations
- Distressed healthcare
- Distressed investing
- Distressed mergers and acquisitions
- Loan portfolio transactions
- Mass tort restructuring
- Municipal and government insolvencies
- Municipal debt
- Business and human rights
- Capital markets
- Corporate compliance and reporting
- Debt capital markets
- Equity capital markets
- Equity private placements
- Class actions and collective litigation
- Securities and shareholder litigation
- Competition/Antitrust, regulation and trade
- Antitrust
- Competition litigation
- Dawn raid support
- EU regulation
- Economic regulation
- Foreign direct investment
- International trade and WTO
- Merger control
- State aid and subsidy control
- Corporate
- Corporate governance
- UK listed companies
- US public companies
- Crisis management
- Defamation and reputation
- Health, safety and environmental crisis management
- Cyber risk advisory
- Data protection and privacy
- Digital Legal Delivery
- ESG and sustainability
- Climate change
- Emerging technology
- Artificial intelligence
- Blockchain, digital assets and Web3
- Metaverse and spatial
- Employment, pensions and incentives
- Employment
- Employment litigation
- Industrial relations
- Pensions and pensions litigation
- Superannuation
- Workplace and employment law training
- Workplace health and safety
- Environment and communities
- Native title and indigenous heritage
- Executive compensation and incentives
- Finance
- Acquisition and leveraged finance
- Asset finance
- Corporate debt finance and treasury
- Derivatives and structured products
- Energy, natural resources and infrastructure finance
- Project finance
- Real estate finance
- Securitization and structured finance
- Sustainable and green finance
- Financial services regulatory
- Compliance advisory
- Enforcement and investigations
- Governance and risk management
- Market conduct
- Regulatory change
- Transactions regulatory support
- Immigration and mobility
- Intellectual property
- Copyright
- Electrical, computer and mechanical IP
- Licensing agreements and corporate transactions
- Patents
- Post-grant proceedings
- Trade marks and design
- Trade secrets
- International arbitration
- Commercial arbitration
- Global advocacy
- Investment arbitration and treaty protection
- Public international law
- Investment management
- Listed funds
- Private funds
- Land use
- Condemnation
- Litigation and dispute resolution
- Advertising disputes
- Africa dispute resolution
- Alternative dispute resolution
- Civil fraud
- Commercial litigation
- Construction and infrastructure disputes
- Directors' liability
- Financial services litigation
- Insurance disputes
- Partnerships and LLPs
- Private wealth and charities
- Product liability
- Professional negligence
- Public law and regulatory
- Public procurement
- TMT disputes
- Tax investigations and disputes
- Trusts and private client disputes
- US False Claims Act litigation
- Mergers and acquisitions
- Joint ventures and investments
- Public mergers and acquisitions
- Private credit
- Private equity
- Projects
- Real estate
- Commercial real estate leasing
- Condominiums
- Construction and engineering
- Corporate real estate
- Planning
- Property taxes
- Real estate acquisitions and sales
- Real estate development
- Real estate funds
- Real estate investment trusts (REITs)
- Real estate joint ventures
- Real estate litigation and dispute resolution
- Real estate preferred equity investments
- Real estate workouts, restructurings and distressed debt
- Sale-leasebacks, ground leases and other hybrid leasing transactions
- Special situations
- Tax
- US state and local tax
- Technology, media and entertainment, and telecommunications
- Digital business
- Outsourcing
- Technology transactions
- US Supreme Court and appellate litigation
- White collar crime and government investigations
- Anti-bribery and corruption
- Anti-money laundering
- Fraud and white collar crime
- Investigations
- Sanctions
- leisure-and-sport/sports-disputes
- Agribusiness
- Automotive
- Connected and autonomous vehicles
- Electrification
- Mobility as a service
- Consumer
- Defence and national security
- Energy
- Energy disputes
- Energy mergers and acquisitions
- Nuclear
- Oil and gas
- Power
- Renewables
- Financial buyers
- Financial services
- Banks
- Fintech
- Insurance
- Government and public sector
- Hospitality and leisure
- Infrastructure
- Airports
- Aviation
- Digital infrastructure
- PPP
- Ports
- Rail
- Roads
- Social infrastructure
- Water and waste
- Manufacturing and industrials
- Media, entertainment and sport
- Gaming and gambling
- Sports
- Mining
- Pharmaceuticals and healthcare
- Diagnostics and medical devices
- Healthcare
- Life Sciences
- Pharmaceuticals
- Pharmaceuticals and healthcare regulatory
- Private capital
- Impact investment
- Impact investors and intermediaries
- Social entrepreneurs
- Leveraged finance
- Real assets: Energy and infrastructure
- Real assets: Real estate
- Venture capital
- Professional support and business services
- Real estate
- Technology
- Semiconductors
- Telecommunications
- Data centres
- Fibre
- Mobile and capacity
- Mobile towers
- Space and satellites
- Subsea cables
- Africa
- Africa Group
- Johannesburg
- Americas
- Latin America Group
- New York
- Silicon Valley
- Washington, DC
- Asia
- Bangkok
- Beijing
- Hong Kong
- India Group
- Jakarta
- Korea Group
- Mainland China
- Malaysia Group
- Shanghai
- Singapore
- Tokyo
- Vietnam Group
- Australia
- Brisbane
- Melbourne
- Perth
- Sydney
- Europe
- Belfast
- Brussels
- Central Asia Group
- Germany
- Kazakhstan Group
- London
- London - Canary Wharf
- Luxembourg
- Madrid
- Milan
- Nordic Group
- Paris
- Switzerland Group
- Ukraine Group
- Middle East
- Dubai
- Israel Group
- Riyadh
Total 7 Results for:
Showing 7 out of 7 results
21 July 2026
US Private M&A Report
19 March 2026
Pharmaceuticals: Deals revival
15 August 2024
Less is more — The premise of the biosimilar ‘patent thicket’ bill
19 July 2024
Just opt out! Boehringer Ingelheim’s IRA challenge is latest to fail
1 May 2024
Potential effects of the Inflation Reduction Act on orphan drug development
20 January 2023
SCOTUS Case With Implications for Attorney-Client Privilege Between CIPOs and C-Suite
Litigation associate Mark H. Russell co-authored an IAM article titled “SCOTUS Case With Implications for Attorney-Client Privilege Between CIPOs and …
10 January 2023
Exploring The Amgen Genus Claims Headed To High Court
Intellectual Property associate Jeffrey Coleman co-authored a Law360 article titled “Exploring The Amgen Genus Claims Headed To High Court” on Jan. 10, …
Showing 7 out of 7 results